Filing Details

Accession Number:
0001209191-23-047525
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-28 16:42:02
Reporting Period:
2023-08-24
Accepted Time:
2023-08-28 16:42:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1740279 In8Bio Inc. INAB Biological Products, (No Disgnostic Substances) (2836) 825462585
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1830914 Tai-Wei William Ho C/O In8Bio, Inc.
350 5Th Ave. Suite 5330
New York NY 10118
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-24 23,800 $1.05 2,339,545 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 72,999 Indirect By child
Common Stock 73,000 Indirect By child
Common Stock 36,500 Indirect See footnote
Common Stock 36,500 Indirect See footnote
Common Stock 36,500 Indirect See footnote
Footnotes
  1. The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.